Jiawei Danxuan Koukang Alleviates Arecoline Induced Oral Mucosal Lesions: Network Pharmacology and the Combined Ultra-High Performance Liquid Chromatography (UPLC) and Mass Spectrometry (MS)
Drug Design, Development and Therapy · 2023
DOI: 10.2147/dddt.s413897 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Linghang Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, 410007, People's Republic of China. Hauptthemen laut MEDLINE: Arecoline, Oral Submucous Fibrosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stomatology, The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, 410007, People's Republic of China.
Zitieren
APA
Zhou, L., Tan, J., Dai, Y., Zhu, K., Xiao, Y., Wu, D., Wang, Z., Tan, Y., & Qin, Y. (2023). Jiawei Danxuan Koukang Alleviates Arecoline Induced Oral Mucosal Lesions: Network Pharmacology and the Combined Ultra-High Performance Liquid Chromatography (UPLC) and Mass Spectrometry (MS). Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s413897
Vancouver
Zhou L, Tan J, Dai Y, Zhu K, Xiao Y, Wu D, et al. Jiawei Danxuan Koukang Alleviates Arecoline Induced Oral Mucosal Lesions: Network Pharmacology and the Combined Ultra-High Performance Liquid Chromatography (UPLC) and Mass Spectrometry (MS). Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s413897
BibTeX
@article{Zhou2023,
author = {Zhou, Linghang and Tan, Jin and Dai, Yuzhe and Zhu, Keke and Xiao, Yanbo and Wu, Dan and Wang, Zongkang and Tan, Yisi and Qin, Yijie},
title = {Jiawei Danxuan Koukang Alleviates Arecoline Induced Oral Mucosal Lesions: Network Pharmacology and the Combined Ultra-High Performance Liquid Chromatography (UPLC) and Mass Spectrometry (MS)},
journal = {Drug Design, Development and Therapy},
year = {2023},
doi = {10.2147/dddt.s413897}
}
EUVIMED